RANDAL J KIRK Insider Trading for August 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RANDAL J KIRK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of RANDAL J KIRK for August 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31 2018 | XON | INTREXON CORP | KIRK RANDAL J | Director | Option Exercise | J | 0.00 | 1,282 | 0 | 129,554 | |
| Aug 31 2018 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Option Exercise | J | 0.00 | 1,282 | 0 | 129,554 | |
| Aug 30 2018 | TBIO | Precipio, Inc. | KIRK RANDAL J | 10% Owner | Sell | S | 0.41 | 500 | 205 | 27,151 | 27.7 K to 27.2 K (-1.81 %) |
| Aug 30 2018 | TBIO | Precipio, Inc. | KIRK RANDAL J | 10% Owner | Sell | S | 0.41 | 4,920 | 2,017 | 266,904 | 271.8 K to 266.9 K (-1.81 %) |
| Aug 30 2018 | TBIO | Precipio, Inc. | KIRK RANDAL J | 10% Owner | Sell | S | 0.41 | 9,340 | 3,829 | 506,657 | 516 K to 506.7 K (-1.81 %) |
| Aug 30 2018 | TBIO | Precipio, Inc. | KIRK RANDAL J | 10% Owner | Sell | S | 0.41 | 9,840 | 4,034 | 533,809 | 543.6 K to 533.8 K (-1.81 %) |
| Aug 28 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 18.02 | 256,860 | 4,628,617 | 1,897,610 | 2.2 M to 1.9 M (-11.92 %) |
| Aug 28 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 18.22 | 64,996 | 1,184,227 | 2,154,470 | 2.2 M to 2.2 M (-2.93 %) |
| Aug 28 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 18.20 | 61,428 | 1,117,990 | 2,219,466 | 2.3 M to 2.2 M (-2.69 %) |
| Aug 28 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 18.02 | 175,389 | 3,160,510 | 3,900,919 | 4.1 M to 3.9 M (-4.30 %) |
| Aug 28 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 18.22 | 44,381 | 808,622 | 4,076,308 | 4.1 M to 4.1 M (-1.08 %) |
| Aug 28 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 18.20 | 41,944 | 763,381 | 4,120,689 | 4.2 M to 4.1 M (-1.01 %) |
| Aug 23 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 18.48 | 149,353 | 2,760,043 | 2,280,894 | 2.4 M to 2.3 M (-6.15 %) |
| Aug 23 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.49 | 464,624 | 8,126,274 | 2,430,247 | 2.9 M to 2.4 M (-16.05 %) |
| Aug 23 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.15 | 95,819 | 1,643,296 | 2,894,871 | 3 M to 2.9 M (-3.20 %) |
| Aug 23 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 18.48 | 101,982 | 1,884,627 | 4,162,633 | 4.3 M to 4.2 M (-2.39 %) |
| Aug 23 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.49 | 317,257 | 5,548,825 | 4,264,615 | 4.6 M to 4.3 M (-6.92 %) |
| Aug 23 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.15 | 65,427 | 1,122,073 | 4,581,872 | 4.6 M to 4.6 M (-1.41 %) |
| Aug 16 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.24 | 56,668 | 976,956 | 2,985,054 | 3 M to 3 M (-1.86 %) |
| Aug 16 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.15 | 54,397 | 932,909 | 3,041,722 | 3.1 M to 3 M (-1.76 %) |
| Aug 16 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.36 | 180,154 | 3,127,473 | 3,096,119 | 3.3 M to 3.1 M (-5.50 %) |
| Aug 16 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.24 | 38,695 | 667,102 | 4,643,451 | 4.7 M to 4.6 M (-0.83 %) |
| Aug 16 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.15 | 37,144 | 637,020 | 4,682,146 | 4.7 M to 4.7 M (-0.79 %) |
| Aug 16 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.36 | 123,014 | 2,135,523 | 4,719,290 | 4.8 M to 4.7 M (-2.54 %) |
| Aug 10 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.08 | 120,606 | 2,059,950 | 3,276,273 | 3.4 M to 3.3 M (-3.55 %) |
| Aug 10 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.48 | 132,591 | 2,317,691 | 3,396,879 | 3.5 M to 3.4 M (-3.76 %) |
| Aug 10 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.52 | 87,185 | 1,527,481 | 3,529,470 | 3.6 M to 3.5 M (-2.41 %) |
| Aug 10 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.08 | 82,353 | 1,406,589 | 4,842,304 | 4.9 M to 4.8 M (-1.67 %) |
| Aug 10 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.48 | 90,536 | 1,582,569 | 4,924,657 | 5 M to 4.9 M (-1.81 %) |
| Aug 10 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.52 | 59,533 | 1,043,018 | 5,015,193 | 5.1 M to 5 M (-1.17 %) |
| Aug 01 2018 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 14.66 | 13,642 | 199,992 | 15,950,961 | 15.9 M to 16 M (+0.09 %) |
| Aug 01 2018 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 15.38 | 52,015 | 799,991 | 1,238,823 | 1.2 M to 1.2 M (+4.38 %) |